InsidersTradesSigma
Follow the Celon Pharma S.A. share price and the full directors' dealings record of the company, a publicly traded company based in Poland. Shares are listed on the PL market, under the authority of KNF. Operating in the Health Care sector, Celon Pharma S.A. has published 2 insider filings. Market capitalisation: €871.6m. The latest transaction was reported on 28 August 2026 (Purchase). Among the most active insiders: Justyna Rejmak. The full history is free.
Analysts rate Celon Pharma S.A. Hold (neutral), based on 5 analysts. Average price target: PLN 20.44.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Celon Pharma S.A. is a company focused on the development of innovative drugs in the healthcare and pharmaceutical sector. It is listed on the XWAR market.